:: Healthcare BizDev ::

Pharmaceutical Care Management Association (PCMA)

601 Pennsylvania Ave, NW

S Bldg Ste 740
Washington , DC 20004 USA

202-207-3610

Company Website:

http://www.pcmanet.org

Newsroom

Contact the Company

Business Focus:

Association: Trade / Professional Society

PBM / Prescription Program

Company Description:

PCMA represents the nation’s pharmacy benefit managers (PBMs), which improve affordability and quality of care through the use of electronic prescribing (e-prescribing), generic alternatives, mail-service pharmacies, and other innovative tools for 210-plus million Americans.

Company Contacts:

Media Contact(s)

Timothy W. Brogan

[Director of Policy Analysis]

Robert Zak

[Director, Marketing and Communication]

Julie Fawcett

[Manager, Communications]

Company Officials:

JC Scott
[President and CEO]

Mark Thierer
[Board Chairman]

Edward M. Feaver PharmD
[Board Director]

Brian McCarthy
[Vice President, Industry Relations & Operations]

Stephanie Kanwit
[Legal Strategist]

Kristin Bass
[Senior Vice President of Policy]

View Additional Employees and Representatives

Andrew Cosgrove
[Vice President - Policy]

Tim Dube
[Assistant Vice President - Regulatory Affairs]

Amanda Frost
[Assistant Vice President - Research]

Greg Johnson
[Assistant Vice President, Federal Affairs]

Regina Stivers
[Director - State Affairs]

Robert Zak
[Director, Marketing and Communication]

Julie Fawcett
[Manager, Communications]

View Past Employees/Others with Past Affiliations

Charles Cote
[Former Vice President - Strategic Communications]

Wendy Krasner
[Retired Vice President of Regulatory Affairs]

Barbara A. Levy
[Retired General Counsel and Vice President, State Affairs]

Mark Merritt
[Former President and Chief Executive Officer]

Company News/Coverage:

PCMA: PBMs Affirm Readiness to Assist Patients with COVID-19

PCMA Names JC Scott New President and CEO

PCMA President and CEO Mark Merritt to Depart At Year-End

PCMA on New PwC Report: PBMs Driving Competition to Reduce Drug Costs

PCMA "PBM Policy Forum" Tackles Prescription Drug Pricing Debate

View all remaining Company News/Coverage headlines

PCMA Launches New Campaign: 'That's What PBMs Do'

PBMs Provide Policy Solutions to Increase Competition, Reduce Rx Costs

PCMA Recruits Scott Kipper as New Vice President of State Affairs

PCMA Outlines 2015 Policy Agenda

PCMA: Lower Cost, Preferred Pharmacies Popular with Seniors in Medicare Part D

PCMA: New OIG Report Cites Drug Manufacturer "Copay Coupon" Use in Medicare Part D

PCMA: New Milliman Study - Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015

PCMA Statement on New CMS Medicare Part D Proposed Rule

PCMA: Eight Ways to Reduce Federal Health Spending and Improve Prescription Drug Benefits in Medicare and Medicaid

PCMA Statement on CMS Analysis of Preferred Pharmacy Networks in Medicare Part D

PCMA: Medicare Trustees Report Shows PBMs are Delivering Savings in Part D

PCMA: Report - Upgrading Medicaid Drug Benefits Could Save Pennsylvania $896 Million

PCMA Report: Upgrading Medicaid Drug Benefits Could Save Federal, State Governments $74.4 Billion

PCMA Recruits Wendy Krasner as New Vice President of Regulatory Affairs

PCMA Statement on Essential Health Benefits Final Rule

PCMA: 88 U.S. Representatives Urge USPS to Preserve Six Day Delivery of Mail-Service Pharmacy

PCMA Statement on Essential Health Benefits Proposed Rule

PCMA: New Study - Reforming Medicaid Pharmacy Saves New York $425 Million in 2012

PCMA Outlines $100 Billion in Prescription Drug Savings to Help Avoid Sequestration Budget Cuts

PCMA: Part D Plans and PBMs Continue to Deliver Savings in Medicare

PCMA: New Study Finds Generic Medications Saved $1 Trillion Over the Last Decade

New PCMA Ad Campaign: 'It's the Drugstore Lobby vs. Employers'

PCMA: Mail-Service Pharmacies Will Save Consumers and Payers Nearly $47 Billion Over the Next Decade

PCMA: Medicare Part D Preferred Pharmacy Networks Reducing Costs, Popular with Seniors

PCMA Launches New Missouri Ad Campaign: 'That's What PBMs Do'

PCMA: Medicare Part D Preferred Pharmacy Networks Reducing Costs, Popular with Seniors

PCMA Launches New Oregon Ad Campaign: 'That's What PBMs Do'

Essential Health Benefits Coalition Statement on HHS Bulletin on Essential Benefits

PCMA: Texas to Modernize Medicaid Rx Benefits, Curb Pharmacy Overpayments

PCMA: New Consumer Survey Finds Overwhelming Satisfaction with Pharmacy Benefits

New PCMA Multimedia Campaign: PBMs Provide Consumers and Payers Increased Savings, Safety, and Convenience

New Coalition Urges HHS to Consider Cost of Health Benefits in Wake of IOM Recommendations

PCMA: Some Essential Benefits Rules Could Worry Small Businesses

PCMA: PBMs Will Save Nearly $2 Trillion in Prescription Drug Costs over the Next Decade

PCMA Outlines $100 Billion in Prescription Drug Savings for Deficit Reduction Committee

PCMA: New Study Finds Mail-Service Pharmacies Improve Adherence to Diabetes Medications in Medicare Part D

PCMA: Part D Plans and PBMs Continue to Deliver Savings in Medicare

Pharmaceutical Care Management Association: GAO - Medicare Part D Plans Expanding Access to New Drugs

PCMA: Study Credits PBM Tools with Reducing Prescription Drug Spending Growth

PCMA Statement on New JAMA Study: Medicare Drug Benefit Reduces Other Medical Costs

PCMA Comments on New Study that Finds Mail-Service Pharmacies Improve Outcomes for Patients Using Cholesterol Medications

PCMA Hails Introduction of Bipartisan Legislation to Increase the Use of Generic Drugs in Medicaid

PCMA: Win for Consumers and Payers: Maine Repeals Costly PBM Fiduciary-Disclosure Law

U.S. Chamber Inducts PCMA President & CEO Mark Merritt to its Committee of Top Trade Assoc. Executives

New NCPA Study: Medicaid Pharmacy Modernization Could Save States Billions Without Limiting Access

PCMA - Setting the Record Straight: Mail-Service Pharmacies Driving Generic Utilization

Generic Drug Industry Honors PCMA President & CEO Mark Merritt with Prestigious ‘Outstanding Contribution’ Award

PCMA: NY State Health Department: Modernize Medicaid Pharmacy to Save $350 Million

PCMA: Generics, Mail-Service Pharmacy Recognized as Ways to Reduce Costs for TRICARE Program

PCMA: Focus on Patients, Not Profits, in Medicaid Pharmacy

PCMA: Florida Could Reduce $462 Million in Wasteful Medicaid Pharmacy Spending

PCMA: HHS Encourages State Medicaid Programs to Use more Generic Drugs

PCMA: Ohio's Medicaid Program Could Save $135 Million

PCMA: It's Time to Fix Michigan's Medicaid Pharmacy Program, Not Defend Wasteful Spending

The Lewin Group: Mississippi Medicaid Could Save $65 Million Over Ten Years by Managing Medicaid Pharmacy More Like Medicare and Commercial Sector Programs

PCMA: Health Affairs Study Finds Substantial Medical Savings When Patients with Vascular Disease Stick to their Medications

PCMA Poll: Voters Want to Reduce Wasteful Spending in Medicaid Pharmacy

PCMA: States, Federal Government Could Save $30 Billion by Managing Medicaid Pharmacy More Like Medicare and Commercial Sector Programs

PCMA: New OIG Report - PBM Negotiations with Pharmacies Lower Drug Prices for Medicare Part D Beneficiaries

PCMA: New Law Ending Immediate Payment for Unverified Claims in Medicare a Step in the Right Direction

PCMA Applauds New CMS Rules Designed to Crack Down on Fraud in Medicare, Medicaid

PCMA: New J.D. Power Study - Mail-Service Pharmacies are Popular with Consumers

PCMA: New CBO Research Finds Use of Generic Drugs in Medicare Part D Saved Beneficiaries and Program $33 Billion in 2007

PCMA Welcomes WellPoint as Newest Member

PCMA: New AARP Study on Brand-Name Drug Price Increases Underscores Need for Greater Use of PBM Cost-Saving Tools

PCMA Statement: CMS: Part D Costs $261 Billion Lower than Expected

PCMA: CMS Turns ‘Transparency’ Spotlight on Drugstores

PCMA: Legislation to Increase Funding to Combat Fraud ‘Critical’ to Enhancing Program Integrity

PCMA Statement on Final EHR ‘Meaningful Use’ Rules

PCMA: Top Federal Appeals Court Strikes Down D.C.'s Controversial PBM Fiduciary Law

PCMA: Disrupting Mail Delivery Schedule Could Negatively Impact Consumers Relying on Home Delivery of Prescription Drugs

PCMA: Drug Company Price Hikes Highlight Need for More Competition in Medicare Part D

URAC Announces Changes to Board of Directors and New Corporate Member Organizations

PCMA: New Legislation Would Increase Prescription Drug Costs, Limit Access

PCMA: Proposed Overhaul of FEHBP Pharmacy BenefitWould Undermine Cost-Saving Tools, Reduce Choices for 8 Million Americans

PCMA Statement: Wrong Time for Congress to Experiment on the Federal Employees Health Benefits Program

PCMA: New Study: Mail-Service Pharmacies Likely To Improve Prescription Drug Adherence

PCMA: New GAO Study: Lack of Competition Helping Drive ‘Extraordinary’ Brand-Name Drug Price Increases

PCMA: Real Biogenerics Reform, Not Pharma Deal ‘Shell Games,’ Will Lower Drug Costs

PCMA's Annual Meeting (October 25-27, 2009)

PCMA Urges Senate Finance Committee to Help Make Prescription Drugs More Affordable for All Americans

PCMA: NCPA ‘Poll’ Contradicts J.D. Power and Associates Survey on Mail-Service Pharmacy

PCMA: New J.D. Power and Associates Study Finds Consumer Satisfaction with Pharmacy Options

PCMA: Improving Affordability Critical to Reforming Health Care

PCMA: New Study Highlights ‘Market-Based’ Reforms to Lower Part D Drug Prices

PCMA: Real Reform Requires a Level Playing Field

PCMA Written Testimony for the U.S. Senate Commerce Subcommittee on Consumer Protection, Product Safety, and Insurance Hearing: “Competition in the Health Care Marketplace”

PCMA on Biogenerics Legislation: A Bellwether for Broader Health Reform Prospects

PCMA Statement on the Administration’s Comments Regarding Financing Health Care Reform

PCMA: New National Generic Pharmaceutical Study Finds Savings of $734 Billion Over the Last Decade

PCMA: New Blue Cross/Blue Shield Prescription-Drug Survey Confirms Generic Drugs Have Gone Mainstream With Consumers, Doctors & Payers

PCMA Launches New Ad Campaign:‘Waiting Isn’t An Option’ for Biogenerics

PCMA: Bipartisan Biogenerics Legislation Will Increase Competition, Lower Costs

URAC to Present at Pharmaceutical Care Management Association (PCMA) PBM Summit

PCMA Study: New Stimulus Law Will Dramatically Increase E-Prescribing Adoption Rate

PCMA: New Bipartisan Biogenerics Legislation the ‘Right Approach’ to Increase Competition, Lower Costs

PCMA on New AARP Study: Biogenerics Will Help Lower Specialty Drug Costs for Consumers

PCMA Appoints Kristin Bass Senior Vice President of Policy

PCMA on Final Economic Stimulus Bill: Important Step Forward to Modernize and Improve Health Care

PCMA: It’s Time for Comparative Effectiveness

PCMA: HIT Bill An Opportunity for Huge Success… or Failure

PCMA: New Commonwealth Fund Survey Shows Patients Are Skipping Care Due to Costs

PCMA: New Analysis Highlights the Need for Rapid Physician Adoption of E-Prescribing

PCMA: New CBO Analysis Confirms Independent Pharmacy 'Collective Bargaining' Legislation Increases Costs for Consumers and Payors

PCMA: HHS Conference on E-Prescribing Will Accelerate Physician Adoption

PCMA: New Medicare Law Igniting Physician Groups to Adopt E-Prescribing

PCMA President and CEO Mark Merritt Testifies Before House Oversight & Government Reform Committee on Medicare Part D

PCMA Statement on Passage of Medicare Bill: E-Prescribing Requirement a Major Victory for Seniors

Center for Health Transformation: New White Paper on Electronic Prescribing - Written and Endorsed by Industry-wide Coalition

New PCMA Ad: Pharmacist 'Prompt Pay' Will Trigger 'Domino Effect' Among Other Medicare Providers

PCMA: Consumers, Businesses, Unions, and Medical Professionals: Time for Congress to Act on E-Prescribing Legislation

PCMA: Skyrocketing Biotech Prices Challenge Employers, Consumers

PCMA: 'Protect Your Pharmacy Week' Should Focus on Safeguarding Part D Anti-Fraud Tools

PCMA: CMS Releases Final E-Prescribing Standards in Medicare

PCMA: Employers - Proven PBM Tools Slowing Cost of Prescription Drug Benefits

PCMA: 2008 Health Debate Highlights 'Workable Solutions' Like E-Prescribing

Prime Therapeutics Joins PCMA

PCMA: CMS Releases Proposed E-Prescribing Standards in Medicare

PCMA’s New Ad Campaign: Require E-Prescribing in Medicare “Before More People Die”

PCMA on Electronic Health Records: The First Step is to Require E-Prescribing in Medicare

PCMA Statement on Independent Pharmacy Antitrust Legislation

PCMA: Coalition of Business, Unions, and Consumer Groups Call on Congress to Require E-Prescribing in Medicare

PCMA Statement on New Average Manufacturer Price (AMP) Legislation

PCMA Statement on the Independent Drugstore Lobby Agenda

E-Prescribing Saving Mississippi Medicaid $1.2 Million Per Month

PCMA: New Report -> Dangerous Drug Side Effects and Deaths Doubled Since 1998... Seniors Hit Hardest

PCMA: Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?

PCMA: Lessons of Katrina Highlight the Need for E-Prescribing in Medicare

PCMA Statement on Part D Survey Published in Health Affairs

PCMA: Minnesota is First in the Nation to Require E-Prescribing

PCMA: Part D Plans Continuing to Provide Robust Savings and Access for Beneficiaries

PCMA Statement Supporting New Average Manufacturer Price (AMP) Legislation

PCMA Statement on The Pharmacy Access Improvement (PhAIm) Act

New IMS Health Report Finds Generic Drugs Used More in Part D than Commercial Market

PCMA: New Report on Prescription Medication Adherence Underscores Importance of E-Prescribing

PCMA: E-Prescribing Could Prevent 1.9 Million Medication Errors, Save $26 Billion

Statement by Zix Corporation Supporting PCMA's e-Prescribing Recommendations

PCMA: New E-Prescribing Initiative a 'Win-Win' For Patients and Physicians

PCMA Statement on Average Manufacturer Price (AMP) Rule in Medicaid

Aetna is PCMA's Newest Member

PCMA: PBMs Paying Clean Claims Within 30-Day Timeframe

RxHub Hosts Second Annual ePrescribing Symposium

PCMA: Beneficiaries in Part D Enjoying Savings and Broad Access on their Prescription Drugs

PCMA: New Study Finds Consumers Have Broad Access to Pharmacy Choices in Urban, Suburban, and Rural Areas

PCMA: New J.D. Power and Associates Study Finds High Consumer Satisfaction with Pharmacy Options

PCMA: National, Uniform Electronic-Prescribing Standard Needed to Increase Physician Adoption

PCMA: PBMs Projected to Save Medicare, Commercial Market $1.3 Trillion on Prescription Drug Costs From 2008-2017

PCMA Welcomes US Script as Newest Member

PCMA Welcomes Scriptrax as Newest Member

PCMA Releases 2007 Policy Agenda

PCMA: PBMs Negotiating Lower Drug Prices in Medicare Part D

PCMA Endorses Legislation to Create a Clear Regulatory Pathway for Biogenerics

PCMA: Seniors Flocking to Lower-Cost Generic Drugs in Medicare Part D

PCMA Supports National Discussion to Promote Value-based Purchasing in Health Care

PCMA: Part D Plans Projected to Save Seniors, Medicare Program $469 Billion over Ten Years

PCMA: Medicare Part B Program Could Save $14 Billion in Prescription Drug Costs through Biogenerics

PCMA: New Survey Showing One in Ten Physicians Use Electronic Prescribing Highlights Need for a National, Uniform Standard

PCMA Welcomes Vidalink as First International Member

The Secret Price Of Drugs

HCBD-PRO Services

Query News -